βTrCP regulates BMI1 protein turnover via ubiquitination and degradation

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cell Cycle

• Publication date

  2011-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.10.8.15372PMID 21430439PMCID PMC3117138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.

  2010cited by this paper
• Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain

  2010cited by this paper
• SnapShot: F box proteins I.

  2009cited by this paper
• Age-dependent Decline in Beta Cell Proliferation Restricts the Capacity of Beta Cell Regeneration in Mice

  2009cited by this paper
• The Polycomb Group Gene Bmi1 Regulates Antioxidant Defenses in Neurons by Repressing p53 Pro-Oxidant Activity

  2009cited by this paper
• Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice

  2009cited by this paper
• Control of cell growth by the SCF and APC/C ubiquitin ligases.

  2009cited by this paper
• Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology.

  2009cited by this paper
• SnapShot: F Box Proteins II.

  2009cited by this paper
• Polycomb Mediated Epigenetic Silencing and Replication Timing at the INK4a/ARF Locus during Senescence

  2009cited by this paper
• BMI1 Cooperates with H-RAS to Induce an Aggressive Breast Cancer Phenotype with Brain Metastases

  2009cited by this paper
• Bmi1 is expressed in vivo in intestinal stem cells

  2008cited by this paper
• SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus

  2008cited by this paper
• Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer

  2008cited by this paper
• "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.

  2008cited by this paper
• Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium.

  2008cited by this paper
• The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

  2007cited by this paper
• Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells.

  2007cited by this paper
• Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior.

  2007cited by this paper
• Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.

  2007influential reference
• BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas

  2006cited by this paper
• Polycomb silencers control cell fate, development and cancer

  2006cited by this paper
• Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.

  2006cited by this paper
• Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a).

  2006cited by this paper
• Ubiquitin ligases: cell-cycle control and cancer

  2006cited by this paper
• Mammary epithelial cell transformation: insights from cell culture and mouse models

  2005cited by this paper
• Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors.

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.

  2005influential reference
• Targeting β-Transducin Repeat–Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells

  2005cited by this paper
• What has senescence got to do with cancer?

  2005cited by this paper
• Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.

  2005influential reference
• Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer.

  2004cited by this paper
• The many faces of β-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer

  2004influential reference
• Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1

  2003cited by this paper
• The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.

  2002influential reference
• Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14ARF Tumor Suppressor

  2000cited by this paper
• β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation

  1999cited by this paper
• The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

  1999cited by this paper
• beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation.

  1999cited by this paper
• A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

  1998cited by this paper
• A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

  1995cited by this paper

• Mitochondrial pyruvate carrier inhibits tumor growth by Bmi1 ubiquitination in renal cell carcinoma progression

  2025cites this paper
• Biology of PEST-containing nuclear proteins as potential targets in ovarian cancer (Review)

  2025cites this paper
• Degrons: defining the rules of protein degradation

  2025cites this paper
• Targeting the BMI1-Noxa axis by Dioscin induces apoptosis in oral squamous cell carcinoma cells

  2025cites this paper
• BMI-1 in Breast Cancer - Biological Role and Clinical Implications.

  2024cites this paper
• Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.

  2023cites this paper
• Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors

  2023cites this paper
• Targeting cancer stemness mediated by BMI1 and MCL1 for non‐small cell lung cancer treatment

  2022cites this paper
• The role of BMI1 in endometrial cancer and other cancers.

  2022cites this paper
• CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway

  2022cites this paper
• p53 inhibits Bmi-1-driven self-renewal and defines salivary gland cancer stemness.

  2022cites this paper
• The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability

  2021cites this paper
• Internal Ribosome Entry Sites Mediate Cap-Independent Translation of Bmi1 in Nasopharyngeal Carcinoma

  2020cites this paper
• Multifaceted behavior of PEST sequence enriched nuclear proteins in cancer biology and role in gene therapy

  2020cites this paper
• BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1

  2019cites this paper
• IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability

  2019cites this paper
• LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1

  2019cites this paper
• Acute Myeloid Leukemia Driven by the CALM-AF10 Fusion Gene is Dependent on BMI1

  2019cites this paper
• Targeting BMI1 and MCL1 for Lung Adenocarcinoma Treatment

  2018cites this paper
• B lymphoma Moloney murine leukemia virus insertion region 1: an oncogenic mediator in prostate cancer

  2018cites this paper
• Ubiquitin‐specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell‐specific Moloney murine leukemia virus integration site 1 for stabilization

  2018cites this paper
• The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein

  2018cites this paper
• A miR-200 c / 141-BMI 1 autoregulatory loop regulates oncogenic activity of BMI 1 in cancer cells

  2017cites this paper
• USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein

  2017cites this paper
• β-transducin repeat-containing E3 ubiquitin protein ligase inhibits migration, invasion and proliferation of glioma cells.

  2017cites this paper
• BMI1, a new target of CK2α

  2017cites this paper
• Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma

  2017cites this paper
• Characterisation of novel regulators of polycombgroup function

  2016cites this paper
• BMI1: A Biomarker of Hematologic Malignancies

  2016cites this paper
• Stuxnet Facilitates the Degradation of Polycomb Protein during Development.

  2016cites this paper
• Polycomb Protein BMI1 Regulates Osteogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Downstream of GSK3

  2016cites this paper
• A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells

  2016cites this paper
• BMI1: A Biomarker of Hematologic Malignancies

  2016cites this paper
• The role of aberrant proteolysis in lymphomagenesis

  2015cites this paper
• Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis.

  2015influential citation
• MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence*

  2015cites this paper
• Bmi-1: At the crossroads of physiological and pathological biology

  2015cites this paper
• Cluster Group Protein BMI 1 via Modulation of the PLK 1 Inhibition Down-regulates Polycomb Molecular Bases of Disease :

  2015cites this paper
• Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival

  2014cites this paper
• Fbxo45 Inhibits Calcium-sensitive Proteolysis of N-cadherin and Promotes Neuronal Differentiation*

  2014cites this paper
• PLK1 Inhibition Down-regulates Polycomb Group Protein BMI1 via Modulation of the miR-200c/141 Cluster*

  2014cites this paper
• Nuclear BMI-1 as a Biomarker in Laryngeal Cancer

  2014cites this paper
• Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation

  2014cites this paper
• The Role of FBXL Subfamily of F-box Proteins in Tumorigenesis

  2014cites this paper
• The Role of BMI1 as a Biomarker of Cancer Stem Cells in Head and Neck Cancer: A Review

  2014cites this paper
• Disruption of Polycomb Repressor Complex-Mediated Gene Silencing Reactivates HIV-1 Provirus in Latently Infected Cells

  2014cites this paper
• microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts

  2013cites this paper
• Sp1 and c‐Myc regulate transcription of BMI1 in nasopharyngeal carcinoma

  2013cites this paper
• A Positive Feedback Loop Regulates the Expression of Polycomb Group Protein BMI1 via WNT Signaling Pathway*

  2012cites this paper
• Microarray-based identification of age-dependent differences in gene expression of human dermal fibroblasts.

  2012cites this paper
• Cellular stress in vitro and longevity in vivo

  2012cites this paper
• Bmi1 Is Down-Regulated in the Aging Brain and Displays Antioxidant and Protective Activities in Neurons

  2012cites this paper
• BMI1 suffers a degrading experience

  2011cites this paper
• Chagas disease

  2011cites this paper
• BMI1: A target of βTrCP

  2011cites this paper